Literature DB >> 32036697

Urethral dysfunction in a rat model of chemically induced prostatic inflammation: potential involvement of the MRP5 pump.

Eduardo C Alexandre1,2, Nailong Cao1, Shinsuke Mizoguchi1, Tetsuichi Saito1, Masahiro Kurobe1, Daisuke Gotoh1, Meri Okorie1, Taro Igarashi1, Edson Antunes2, Naoki Yoshimura1.   

Abstract

Prostate inflammation (PI) is a clinical condition associated with infection and/or inflammation of the prostate. It is a common disease frequently associated to lower urinary tract (LUT) symptoms. The urethra is an understudied structure in the LUT and plays a fundamental role in the urinary cycle. Here, we proposed to evaluate the effect of PI on the urethra tissue. Male Sprague-Dawley rats were used, and PI was induced by formalin injection into the ventral lobes of the prostate. The pelvic urethra at the prostatic level was harvested for histological analysis, contraction (electrical field stimulation and phenylephrine), and relaxation (sodium nitroprusside/MK-571) experiments. Various gene targets [cytochrome c oxidase subunit 2, transforming growth factor-β1, interleukin-1β, hypoxia-inducible factor-1α, α1A-adrenoceptor, inositol 1,4,5-trisphosphate receptor type 1, voltage-gated Ca2+ channel subunit-α1D, neuronal nitric oxide synthase, soluble guanylyl cyclase, phosphodiesterase 5A, protein kinase CGMP-dependent 1, and multidrug resistance-associated protein 5 (MRP5; ATP-binding cassette subfamily C member 5)] were quantified, and cGMP levels were measured. No histological changes were detected, and functional assays revealed decreased contraction and increased relaxation of urethras from the PI group. The addition of MK-571 to functional assays increased urethral relaxation. Genes associated with inflammation were upregulated in urethras from the PI group, such as cytochrome oxidase c subunit 2, transforming growth factor-β1, interleukin-1β, and hypoxia-inducible factor-1α. We also found increased expression of L-type Ca2+ channels and the neuronal nitric oxide synthase enzyme and decreased expression of the MRP5 pump. Finally, cGMP production was enhanced in urethral tissue of PI animals. The results indicate that PI is associated with proinflammatory gene expression in the urethra without histologically evident inflammation and that PI produces a dysfunctional urethra and MRP5 pump downregulation, which results in cGMP accumulation inside the cell. These findings would help to better understand LUT dysfunctions associated with PI and the role of MRP pumps in the control of LUT function.

Entities:  

Keywords:  cGMP; electrical field stimulation; multidrug resistance-associated protein 5; phenylephrine; prostatitis

Mesh:

Substances:

Year:  2020        PMID: 32036697      PMCID: PMC7099503          DOI: 10.1152/ajprenal.00566.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  49 in total

1.  NIH consensus definition and classification of prostatitis.

Authors:  J N Krieger; L Nyberg; J C Nickel
Journal:  JAMA       Date:  1999-07-21       Impact factor: 56.272

Review 2.  Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases.

Authors:  An-Kui Yang; Zhi-Wei Zhou; Min Qian Wei; Jun-Ping Liu; Shu-Feng Zhou
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

3.  Effects of Estrogen Receptor β Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.

Authors:  Shinsuke Mizoguchi; Kenichi Mori; Zhou Wang; Teresa Liu; Yasuhito Funahashi; Fuminori Sato; Donald B DeFranco; Naoki Yoshimura; Hiromitsu Mimata
Journal:  Prostate       Date:  2017-02-09       Impact factor: 4.104

4.  The role of prostaglandin and E series prostaglandin receptor type 4 receptors in the development of bladder overactivity in a rat model of chemically induced prostatic inflammation.

Authors:  Shinsuke Mizoguchi; Amanda S Wolf-Johnson; Jianshu Ni; Kenichi Mori; Takahisa Suzuki; Eiichiro Takaoka; Hiromitsu Mimata; Donald B DeFranco; Zhou Wang; Lori A Birder; Naoki Yoshimura
Journal:  BJU Int       Date:  2019-06-26       Impact factor: 5.588

Review 5.  Cellular efflux of cAMP and cGMP - a question about selectivity.

Authors:  Georg Sager; Aina Westrheim Ravna
Journal:  Mini Rev Med Chem       Date:  2009-07       Impact factor: 3.862

6.  Involvement of nitric oxide and cyclic GMP in rabbit urethral relaxation.

Authors:  S Dokita; S D Smith; T Nishimoto; M A Wheeler; R M Weiss
Journal:  Eur J Pharmacol       Date:  1994-02-15       Impact factor: 4.432

Review 7.  LUTS treatment: future treatment options.

Authors:  K-E Andersson
Journal:  Neurourol Urodyn       Date:  2007-10       Impact factor: 2.696

8.  Changes in nerve-mediated contractility of the lower urinary tract in a mouse model of premature ageing.

Authors:  D Triguero; A Lafuente-Sanchis; A Garcia-Pascual
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 9.  Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.

Authors:  Božo Krušlin; Davor Tomas; Tihana Džombeta; Marija Milković-Periša; Monika Ulamec
Journal:  Front Oncol       Date:  2017-04-25       Impact factor: 6.244

10.  Time-Dependent Changes of Urethral Function in Diabetes Mellitus: A Review.

Authors:  Nailong Cao; Baojun Gu; Daisuke Gotoh; Naoki Yoshimura
Journal:  Int Neurourol J       Date:  2019-06-30       Impact factor: 2.835

View more
  2 in total

1.  Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury.

Authors:  Daisuke Gotoh; Tetsuichi Saito; Sergei Karnup; Yosuke Morizawa; Shunta Hori; Yasushi Nakai; Makito Miyake; Kazumasa Torimoto; Kiyohide Fujimoto; Naoki Yoshimura
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-11

2.  Lipopolysaccharide reduces urethral smooth muscle contractility via cyclooxygenase activation.

Authors:  Fabiano B Calmasini; Eduardo C Alexandre; Mariana G Oliveira; Fábio H Silva; António G Soares; Soraia K P Costa; Edson Antunes
Journal:  J Physiol Biochem       Date:  2021-05-21       Impact factor: 4.158

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.